Previous studies have shown that the therapeutic administration of CD1d-expressing DCs pulsed with α-GalCer (forming α-GalCer-CD1d complex) inhibited tumor growth and metastasis and prolonged the survival of tumor-bearing hosts compared with free α-GalCer administration [18,19,20]. The gene discussed is CD1D; the disease is neoplasm.